- Filed
- Mar 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Dec 31, 2023 | 17.74M sh |
| Capex | FY 2024 · Dec 31, 2023 | $13.7M |
| Long Term Debt restated | FY 2024 · Dec 31, 2023 | $238.7M |
| Short Term Debt restated | FY 2024 · Dec 31, 2023 | $35.6M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $58.9M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $395M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $820.7M |
| Current Assets | FY 2024 · Dec 31, 2023 | $480.8M |
| Total Assets | FY 2024 · Dec 31, 2023 | $926.3M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$12.15 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$12.15 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $347.3M |
| Net Income | FY 2024 · Dec 31, 2023 | −$215.5M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$69.5M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $359.9M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $1.01B |
| Revenue | FY 2024 · Dec 31, 2023 | $1.37B |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $206M |